🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessing Chronic Pain Patient Preferences

RecruitingNAAges 18 Years - anyAllUniversité Catholique de Louvain
NCT07453524 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to ask chronic pain patients their preferences regarding which side effects of pain medications are least acceptable in relation to their pain relief benefits. This information may help in the selection of improved treatment options in the future.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged over 18 years. * Being treated with pain medication. * (Chronic-)Pain for at least 3 months. * Capacity to understand and provide an informed consent form. Exclusion Criteria: * Insufficient French or English language skills. * Epilepsy treated by an anti-epileptic. * Alzheimer's disease. * Parkinson's disease
💊

What it tests

  • Patient questionnaire
📍

Where

1 site
UCLouvain/IONS
Brussels, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy